WHO backs Ervebo Vaccine trial against Bundibugyo virus in DR Congo
The World Health Organisation’s Technical Advisory Group has recommended that the Ervebo vaccine be prioritised for a randomised clinical trial against Bundibugyo virus disease in the Democratic Republic of Congo. The recommendation followed preliminary animal-study findings suggesting that Ervebo may provide some cross-protection against the virus, particularly in reducing deaths. WHO said experts found no…
